Results 81 to 90 of about 2,823 (147)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review. [PDF]

JNMA J Nepal Med Assoc
Bashyal S, Karki M, Shah D.
europepmc   +1 more source

Impact of Age on Lipid-Lowering Therapy Prescriptions and LDL-Cholesterol Control: Insights from the PORTRAIT-DYS Study. [PDF]

Glob Heart
Gavina C, Seabra D, Oliveira S, Teixeira C, Ruivo JA, Lourenço-Silva N, Luz AR, Jácome C, Araújo F.   +8 more
europepmc   +1 more source

Impact of Antihypertensive, Antihyperlipidemic, and Mixed Antidepressant Medications on Dental Implant Success: A Retrospective Cohort Study. [PDF]

Cureus
Chidiac A, Kachouh C, M Sadaka R, Bassil J.   +3 more
europepmc   +1 more source

PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial. [PDF]

BMJ Open
Chen Z, Ma S, Zhang J, Zhang R, Zhou M, Li C, Chen Y, Wang H, He Y, REPRESS trial investigator.   +9 more
europepmc   +1 more source

Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide. [PDF]

Intern Med
Kojima N, Tada H, Takamura M.
europepmc   +1 more source

Prevalence and Medical Treatment of Arterial Hypertension and Hypercholesterolemia in Germany: a Nationwide questionnaire-based Survey in Medical Practices. [PDF]

High Blood Press Cardiovasc Prev
Beger C, Randerath O, Mayerböck A, Klein K, Limbourg FP.   +4 more
europepmc   +1 more source

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Goh S, Huh KY, Lee S, Cho JY, Yu KS.
europepmc   +1 more source

Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.

Cardiorenal Med
Dello Strologo A, Franculli A, Saporito P, Miani N, Bellasi A, Lido P, Di Lullo L, Ronco C, Peverini P.   +8 more
europepmc   +1 more source

Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial Infarction. [PDF]

Pharmacoepidemiol Drug Saf
Cars T, Gustafsson S, Chan Q, Dhalwani N, Kent ST, Briggs A, Gale CP, Gitt A, Jukema JW, Steg PG, Sundström J, James S, Hagström E, Brookhart MA.   +13 more
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Target Attainment in Lithuania: A Nationwide Analysis of Real-World Health Data. [PDF]

Medicina (Kaunas)
Urbonas G, Lapinskas T, Čeponienė I, Vasiliauskienė O, Umbrasienė J, Grabauskytė I, Plisienė J.   +6 more
europepmc   +1 more source